Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 62 citing Mattioni: Amiodarone in patients with previous drug-mediated torsade de pointes: long-term.... (0.08 sec) 

Task force on sudden cardiac death of the European Society of Cardiology

- oxfordjournals.org [PDF] 
SG Priori, E Aliot, C Blomstrom-Lundqvist, L … - European heart …, 2001 - Eur Soc Cardiology
The members of the Task Force on Sudden Death dedicate this paper to the memory of our former
friend and colleague, Professor Ronald WF Campbell. Ronnie spent his life working in the field
of sudden cardiac death; he contributed much and helped many. But his own life fell ...
Cited by 731 - Related articles - BL Direct - All 14 versions

Female gender as a risk factor for torsades de pointes associated with …


RR Makkar, BS Fromm, RT Steinman, MD Meissner, … - Jama, 1993 - Am Med Assoc
OBJECTIVE--To test the hypothesis that female prevalence is greater than expected among reported
cases of torsades de pointes associated with cardiovascular drugs that prolong cardiac
repolarization. DATA SOURCES--A MEDLINE search of the English-language literature ...
Cited by 509 - Related articles - BL Direct - All 6 versions

Precordial QT interval dispersion as a marker of torsade de pointes. Disparate …

- ahajournals.org [PDF] 
JT Hii, DG Wyse, AM Gillis, HJ Duff, MA Solylo, LB … - Circulation, 1992 - Am Heart Assoc
John TY Hii, BMBS; D. George Wyse, MD, PhD; Anne M. Gillis, MD; Henry J. Duff, MD; ... Michael
A. Solylo, MD; and L. Brent Mitchell, MD ... Background. Patients with a history of class Ia
drug-induced torsade de pointes have been treated with ... T he ECG QT interval reflects ...
Cited by 385 - Related articles - BL Direct - All 5 versions

Electrophysiologic mechanisms of the long QT interval syndromes and torsade de …

- annals.org
HL Tan, CJY Hou, MR Lauer, RJ Sung - Annals of internal medicine, 1995 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Purpose: To review the current
understanding of the mechanisms and treatment of the long QT interval syndromes and ...
Cited by 201 - Related articles - BL Direct - All 3 versions

Suppression of time-dependent outward current in guinea pig ventricular myocytes. …

- ahajournals.org [PDF] 
JR Balser, PB Bennett, LM Hondeghem, DM … - Circulation research, 1991 - Am Heart Assoc
Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division
of Wolters ... Jeffrey R. Balser, Paul B. Bennett, Luc M. Hondeghem, and
Cited by 171 - Related articles - All 5 versions

Frequency-dependent electrophysiologic effects of amiodarone in humans

- ahajournals.org [PDF] 
PT Sager, P Uppal, C Follmer, M Antimisiaris, C Pruitt, … - Circulation, 1993 - Am Heart Assoc
Philip T. Sager, MD; Parveen Uppal, MD; Christopher Follmer, PhD; Michael Antimisiaris,
MD; ... Clara Pruitt, RN; Bramah N. Singh, MD, DPhil ... Background. In general, antiarrhythmic
agents that prolong the action potential duration (APD) have attenuated effects on ...
Cited by 117 - Related articles - BL Direct - All 5 versions

Drug interactions with cisapride: clinical implications


EL Michalets, CR Williams - Clinical pharmacokinetics, 2000 - ingentaconnect.com
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49 1. Pharmacokinetics of Cisapride
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51 2. Cytochrome P450 (CYP) 3A4 . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . 51 3. Cardiac Adverse Effects of Cisapride . . . . . . . . . . . . . . ...
Cited by 104 - Related articles - BL Direct - All 4 versions

Risks and benefits of antiarrhythmic therapy


DM Roden - New England Journal of Medicine, 1994 - content.nejm.org
Drug treatment of cardiac arrhythmias is not uniformly effective and frequently causes side
effects. Recently, new data have become available that more clearly delineate the risks of
antiarrhythmic-drug therapy. At the same time, establishing a benefit of treatment with ...
Cited by 104 - Related articles - BL Direct - All 6 versions

Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT …

- ahajournals.org
JM van Opstal, M Schoenmakers, SC Verduyn, SH De … - Circulation, 2001 - Am Heart Assoc
Methods and Results— Amiodarone (n=7, 40 mg · kg -1 · d -1 ) and dronedarone (n=8, 20
mg/kg BID) were started at 6 weeks of CAVB (baseline). Six dogs served as controls. Surface
ECGs and endocardially placed monophasic action potential catheters in the left (LV) and ...
Cited by 103 - Related articles - BL Direct - All 6 versions

Drug block of I Kr: model systems and relevance to human arrhythmias


T Yang, D Snyders, DM Roden - Journal of cardiovascular …, 2001 - journals.lww.com
Summary: The long QT-related arrhythmia torsades de pointes (TdP) can arise with mutations
in HERG and during treatment with drugs that block cardiac IKr, the current encoded by
HERG. Multiple test systems have been used to assess drug block of IKr. This study ...
Cited by 101 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google